DoW Rare Cancers Idea Development Award
Agency: Defense Health Agency Contracting Activity - DHACA
Assistance Listings: 12.420 -- Military Medical Research and Development
Description
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation.
Distinctive Features:
- The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
- Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.
- Research should have high potential impact on rare cancers and the patient community.
Eligibility
Eligible applicants
Miscellaneous
- Unrestricted
Additional information
Grantor contact information
Description
eBRAP Help Desk
Documents
| File name | Description | Last updated |
|---|---|---|
| HT942526RCRPIDA_GG.pdf | FY26 RCRP IDA Program Announcement | Jun 17, 2026 05:50 PM UTC |
Link to additional information
--
Closing: November 18, 2026
Award
$7,350,000
Program Funding
15
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
HT942526RCRPIDA
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
1
Posted date:
June 17, 2026
Archive date:
December 18, 2026
